secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXICURE, INC. (XCUR)
CIK:        0001698530
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001698530-25-000004
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exicure buys GPCR USA for ~$1.62M; milestone & royalty deal with GPCR Therapeutics
--------------------------------------------------------------------------------

- Acquired all outstanding shares of GPCR Therapeutics USA from GPCR Therapeutics for ~$0.27/share (total ~$1.62M).
- Entered License and Collaboration Agreement to develop and commercialize GPCR's IP; includes milestone payments and 10% royalty on net sales.
- Example milestone: $30M payment when first annual net sales exceed $400M.
- Deal closed concurrently with execution on January 19, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1698530/000169853025000004/0001698530-25-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1698530/000169853025000004/xcur-20250119.htm
  HTML page:      https://secwatch.observer/filing/0001698530-25-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer